Maralixibat Chloride
Who holds supplier records for Maralixibat Chloride? 4 organisations hold a current record for Maralixibat Chloride: an active US FDA Type II Drug Master File. Recorded organisation countries for current records: India (2) and China (1); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records
Cite as: PharmaTek, “Maralixibat Chloride: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/maralixibat-chloride
Reading the evidence
- 4 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
2 of the 3 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 2 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (4)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Maralixibat Chloride. Country is the organisation's recorded country, not necessarily the manufacturing site.
- APICORE LLC (A WHOLLY OWNED SUB OF RK PHARMA INC)Active DMF 41516 · latest filing Apr 2025
- BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITEDIndiaActive DMF 41809 · latest filing Apr 2025
- HONOUR LAB LTDIndia Company GMP cert on recordActive DMF 42238 · latest filing Jul 2025
- Zhejiang Ausun Pharmaceutical Co., Ltd.China Company GMP cert on recordActive DMF 41496 · latest filing Mar 2025
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Maralixibat Chloride is a selective inhibitor of the ileal bile acid transporter (IBAT/ASBT) indicated for the treatment of cholestatic pruritus in patients with Alagille syndrome. This therapeutic agent works by reducing the reabsorption of bile acids in the intestine, thereby lowering bile acid levels in patients.
Chemical identity
- IUPAC name
- (4R,5R)-5-[4-[[4-(4-aza-1-azoniabicyclo[2.2.2]octan-1-ylmethyl)phenyl]methoxy]phenyl]-3,3-dibutyl-7-(dimethylamino)-1,1-dioxo-4,5-dihydro-2H-1lambda6-benzothiepin-4-ol chloride
- Canonical SMILES
- CCCCC1(CS(=O)(=O)C2=C(C=C(C=C2)N(C)C)[C@H]([C@H]1O)C3=CC=C(C=C3)OCC4=CC=C(C=C4)C[N+]56CCN(CC5)CC6)CCCC.[Cl-]
- InChIKey
- POMVPJBWDDJCMP-RUKDTIIFSA-M
- Synonyms
- Livmarli API, livmarli, lopixibat chloride, lum-001, lum001
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Ileal Bile Acid Transporter Inhibitor
- Mechanism of action
- Ileal Bile Acid Transporter Inhibitors; Organic Anion Transporting Polypeptide 2B1 Inhibitors
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Maralixibat Chloride?
4 organisations hold an active US FDA Type II Drug Master File or a CEP for Maralixibat Chloride: APICORE LLC (A WHOLLY OWNED SUB OF RK PHARMA INC), BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (India), HONOUR LAB LTD (India) and Zhejiang Ausun Pharmaceutical Co., Ltd. (China). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Maralixibat Chloride Drug Master Files are active?
APICORE LLC (A WHOLLY OWNED SUB OF RK PHARMA INC) (DMF 41516), BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (DMF 41809), HONOUR LAB LTD (DMF 42238) and Zhejiang Ausun Pharmaceutical Co., Ltd. (DMF 41496). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
How do I qualify a Maralixibat Chloride supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Maralixibat Chloride?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.